PL
ABBV icon

Pluribus Labs’s AbbVie ABBV Stock Holding History

Pluribus Labs’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$269K Sell
1,754
-360
-17% -$55K 0.49% 72
2022
Q1 		$343K Buy
+2,114
New +$307K 1.36% 22

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Pluribus Labs's ABBV Position: Q2 2022 in Review

Pluribus Labs reduced its AbbVie (ABBV) stake by 17% in Q2 2022, selling an estimated $55K and leaving 1,754 shares worth $269K. The position accounts for 0.49% of the portfolio, ranked #72.

Pluribus Labs first reported a position in ABBV in Q1 2022 and has held it in 2 quarters since. The position peaked at $343K in Q1 2022. 3,004 funds tracked by Wall St. Rank hold ABBV as of Q2 2022.

  • Pluribus Labs held 1,754 shares of AbbVie worth $269K as of Q2 2022.
  • Pluribus Labs sold 360 AbbVie shares in Q2 2022, an estimated $55K.
  • AbbVie made up 0.49% of Pluribus Labs's portfolio in Q2 2022, its #72 holding.
  • Pluribus Labs first reported a position in AbbVie in Q1 2022 and has held it in 2 quarters since.
  • Pluribus Labs's AbbVie position peaked at $343K in Q1 2022.
  • 3,004 funds tracked by Wall St. Rank held AbbVie as of Q2 2022.

Based on Pluribus Labs's 13F filing for Q2 2022, filed 12 Aug 2022.